Conolidine’s analgesic results stem from its interaction with non-opioid pain pathways. Not like opioids, which bind to µ-opioid receptors during the central anxious program, conolidine modulates alternate molecular targets. A Science Improvements study found that conolidine interacts with the atypical chemokine receptor ACKR3/CXCR7, which regulates opioid peptide availability. By https://alternativenaturalpainrel50391.blogdun.com/39533351/alternative-natural-pain-relief-to-replace-traditional-painkillers-secrets